Details
Stereochemistry | ACHIRAL |
Molecular Formula | C34H32N4O4.Fe |
Molecular Weight | 616.487 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[Fe++].CC1=C(CCC(O)=O)C2=CC3=NC(=CC4=C(C)C(C=C)=C([N-]4)C=C5N=C(C=C1[N-]2)C(C=C)=C5C)C(C)=C3CCC(O)=O
InChI
InChIKey=KABFMIBPWCXCRK-RGGAHWMASA-L
InChI=1S/C34H34N4O4.Fe/c1-7-21-17(3)25-13-26-19(5)23(9-11-33(39)40)31(37-26)16-32-24(10-12-34(41)42)20(6)28(38-32)15-30-22(8-2)18(4)27(36-30)14-29(21)35-25;/h7-8,13-16H,1-2,9-12H2,3-6H3,(H4,35,36,37,38,39,40,41,42);/q;+2/p-2/b25-13-,26-13-,27-14-,28-15-,29-14-,30-15-,31-16-,32-16-;
Molecular Formula | Fe |
Molecular Weight | 55.845 |
Charge | 2 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | C34H32N4O4 |
Molecular Weight | 560.6423 |
Charge | -2 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/21371326Curator's Comment: description was created based on several sources, including:
https://www.ncbi.nlm.nih.gov/pubmed/9057849
Sources: https://www.ncbi.nlm.nih.gov/pubmed/21371326
Curator's Comment: description was created based on several sources, including:
https://www.ncbi.nlm.nih.gov/pubmed/9057849
Ferroheme is formed when iron is inserted into protoporphyrin IX. The active center of hemoglobin and myoglobin consists of iron Ferroheme complex bound through a single, “proximal”, axial histidine (His) to the protein It is an iron containing cofactor that is involved with a wide range of cellular functions including oxygen transport. The antimalarial activity of a number of artemisinin derivatives, both newly synthesized and currently used as drugs, against Plasmodium falciparum in culture shows a correlation with their affinity of binding with Ferroheme.
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Additive effect of erythropoietin and heme on murine hematopoietic recovery after azidothymidine treatment. | 1993 Dec 15 |
|
Long-term bone marrow stromal and hemopoietic toxicity to AZT: protective role of heme and IL-1. | 1993 Feb |
|
Identification of a second region upstream of the mouse heme oxygenase-1 gene that functions as a basal level and inducer-dependent transcription enhancer. | 1995 May 19 |
|
The heme-responsive element of the mouse heme oxygenase-1 gene is an extended AP-1 binding site that resembles the recognition sequences for MAF and NF-E2 transcription factors. | 1996 Apr 25 |
|
Inhibition of human immunodeficiency virus-1 reverse transcriptase by heme and synthetic heme analogs. | 1996 Jan |
|
Mechanism of induction of heme oxygenase by metalloporphyrins in primary chick embryo liver cells: evidence against a stress-mediated response. | 1997 Apr |
|
Regulation of expression of the human heme oxygenase-1 gene in transfected chick embryo liver cell cultures. | 1997 Jun 26 |
|
Non-iron metalloporphyrins: potent antibacterial compounds that exploit haem/Hb uptake systems of pathogenic bacteria. | 1999 Jan |
|
Mechanism of heme oxygenase-1 gene activation by cadmium in MCF-7 mammary epithelial cells. Role of p38 kinase and Nrf2 transcription factor. | 2000 Sep 8 |
|
Cadmium induces nuclear export of Bach1, a transcriptional repressor of heme oxygenase-1 gene. | 2003 Dec 5 |
|
The heme-heme oxygenase system: a molecular switch in wound healing. | 2003 Jul 15 |
|
An internal enhancer regulates heme- and cadmium-mediated induction of human heme oxygenase-1. | 2003 Sep |
|
The role of endogenous heme synthesis and degradation domain cysteines in cellular iron-dependent degradation of IRP2. | 2003 Sep-Oct |
|
Identification of key elements that are responsible for heme-mediated induction of the avian heme oxygenase-1 gene. | 2004 Aug 12 |
|
Heme oxygenase-1 inhibits angiotensin II-induced cardiac hypertrophy in vitro and in vivo. | 2004 Jul 20 |
|
Enhancement of heme-induced membrane damage by the anti-malarial clotrimazole: the role of colloid-osmotic forces. | 2004 Mar |
|
Upstream stimulatory factors, USF1 and USF2, bind to the human haem oxygenase-1 proximal promoter in vivo and regulate its transcription. | 2004 Oct 15 |
|
Identification of a human heme exporter that is essential for erythropoiesis. | 2004 Sep 17 |
|
Allosteric modulation of anti-HIV drug and ferric heme binding to human serum albumin. | 2005 Dec |
|
Differential gene expression in rat colon by dietary heme and calcium. | 2005 Jan |
|
Dynamic cytoplasmic anchoring of the transcription factor Bach1 by intracellular hyaluronic acid binding protein IHABP. | 2005 Mar |
|
Up-regulation of heme oxygenase provides vascular protection in an animal model of diabetes through its antioxidant and antiapoptotic effects. | 2006 Dec |
|
Identification of heme as the ligand for the orphan nuclear receptors REV-ERBalpha and REV-ERBbeta. | 2007 Dec |
|
Rev-erbalpha, a heme sensor that coordinates metabolic and circadian pathways. | 2007 Dec 14 |
|
Heme induces endothelial tissue factor expression: potential role in hemostatic activation in patients with hemolytic anemia. | 2008 Dec |
|
Heme oxygenase-1 induction depletes heme and attenuates pulmonary artery relaxation and guanylate cyclase activation by nitric oxide. | 2008 Mar |
|
Regulation of heme synthesis and proteasomal activity by copper: possible implications for Wilson's disease. | 2009 |
|
15-Deoxy-Delta12,14-prostaglandin J2 upregulates the expression of heme oxygenase-1 and subsequently matrix metalloproteinase-1 in human breast cancer cells: possible roles of iron and ROS. | 2009 Apr |
|
Preparation of a biologically active apo-cytochrome b5 via heterologous expression in Escherichia coli. | 2009 Aug |
|
Protein assay for heme oxygenase-1 (HO-1) induced by chemicals in HepG2 cells. | 2009 Dec |
|
Role for copper in the cellular and regulatory effects of heme-hemopexin. | 2009 Jun |
|
Comparative analysis of gene expression changes mediated by individual constituents of hemozoin. | 2009 Mar 16 |
|
Pro-healing potential of hemin: an inducer of heme oxygenase-1. | 2010 Oct 25 |
|
Lon peptidase 1 (LONP1)-dependent breakdown of mitochondrial 5-aminolevulinic acid synthase protein by heme in human liver cells. | 2011 Jul 29 |
|
DiGeorge critical region 8 (DGCR8) is a double-cysteine-ligated heme protein. | 2011 May 13 |
|
Concomitant induction of heme oxygenase-1 attenuates the cytotoxicity of arsenic species from lumbricus extract in human liver HepG2 cells. | 2012 Apr |
|
Enhancement of nitrite on heme-induced oxidative reactions: A potential toxicological implication. | 2012 Feb |
|
Heme and heme biosynthesis intermediates induce heme oxygenase-1 and cytochrome P450 2A5, enzymes with putative sequential roles in heme and bilirubin metabolism: different requirement for transcription factor nuclear factor erythroid- derived 2-like 2. | 2012 Nov |
|
Structure of REV-ERBβ ligand-binding domain bound to a porphyrin antagonist. | 2014 Jul 18 |
|
Nitration of Y10 in Aβ1-40: is it a compensatory reaction against oxidative/nitrative stress and Aβ aggregation? | 2015 Mar 16 |
|
Key roles for tyrosine 10 in aβ-heme complexes and its relevance to oxidative stress. | 2015 Mar 16 |
Patents
Sample Use Guides
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/508805
The matrix fraction of rat liver mitochondria has a high binding capacity for protoheme IX with an almost linear increase in binding up to at least 28 nmol heme/mg protein. Since free heme could not be detected until the heme to protein ratio exceeded 14 nmol heme/mg protein, it is suggested that there is a substantial high-affinity binding of heme to matrix components, probably those of high molecular weight and low electrophoretic mobility.
Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 20:17:31 GMT 2025
by
admin
on
Mon Mar 31 20:17:31 GMT 2025
|
Record UNII |
42VZT0U6YR
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
EU-Orphan Drug |
EU/3/13/1149
Created by
admin on Mon Mar 31 20:17:31 GMT 2025 , Edited by admin on Mon Mar 31 20:17:31 GMT 2025
|
||
|
NCI_THESAURUS |
C764
Created by
admin on Mon Mar 31 20:17:31 GMT 2025 , Edited by admin on Mon Mar 31 20:17:31 GMT 2025
|
||
|
FDA ORPHAN DRUG |
402413
Created by
admin on Mon Mar 31 20:17:31 GMT 2025 , Edited by admin on Mon Mar 31 20:17:31 GMT 2025
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
SUB14075MIG
Created by
admin on Mon Mar 31 20:17:31 GMT 2025 , Edited by admin on Mon Mar 31 20:17:31 GMT 2025
|
PRIMARY | |||
|
C538
Created by
admin on Mon Mar 31 20:17:31 GMT 2025 , Edited by admin on Mon Mar 31 20:17:31 GMT 2025
|
PRIMARY | |||
|
HEME B
Created by
admin on Mon Mar 31 20:17:31 GMT 2025 , Edited by admin on Mon Mar 31 20:17:31 GMT 2025
|
PRIMARY | |||
|
60344
Created by
admin on Mon Mar 31 20:17:31 GMT 2025 , Edited by admin on Mon Mar 31 20:17:31 GMT 2025
|
PRIMARY | |||
|
17627
Created by
admin on Mon Mar 31 20:17:31 GMT 2025 , Edited by admin on Mon Mar 31 20:17:31 GMT 2025
|
PRIMARY | |||
|
30413
Created by
admin on Mon Mar 31 20:17:31 GMT 2025 , Edited by admin on Mon Mar 31 20:17:31 GMT 2025
|
PRIMARY | |||
|
D006418
Created by
admin on Mon Mar 31 20:17:31 GMT 2025 , Edited by admin on Mon Mar 31 20:17:31 GMT 2025
|
PRIMARY | |||
|
42VZT0U6YR
Created by
admin on Mon Mar 31 20:17:31 GMT 2025 , Edited by admin on Mon Mar 31 20:17:31 GMT 2025
|
PRIMARY | |||
|
26355
Created by
admin on Mon Mar 31 20:17:31 GMT 2025 , Edited by admin on Mon Mar 31 20:17:31 GMT 2025
|
PRIMARY | |||
|
m5944
Created by
admin on Mon Mar 31 20:17:31 GMT 2025 , Edited by admin on Mon Mar 31 20:17:31 GMT 2025
|
PRIMARY | Merck Index | ||
|
267100
Created by
admin on Mon Mar 31 20:17:31 GMT 2025 , Edited by admin on Mon Mar 31 20:17:31 GMT 2025
|
PRIMARY | |||
|
14875-96-8
Created by
admin on Mon Mar 31 20:17:31 GMT 2025 , Edited by admin on Mon Mar 31 20:17:31 GMT 2025
|
PRIMARY | |||
|
DTXSID90889386
Created by
admin on Mon Mar 31 20:17:31 GMT 2025 , Edited by admin on Mon Mar 31 20:17:31 GMT 2025
|
PRIMARY | |||
|
SUB30447
Created by
admin on Mon Mar 31 20:17:31 GMT 2025 , Edited by admin on Mon Mar 31 20:17:31 GMT 2025
|
PRIMARY | |||
|
100000093418
Created by
admin on Mon Mar 31 20:17:31 GMT 2025 , Edited by admin on Mon Mar 31 20:17:31 GMT 2025
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE |
|